MORISCO, FILOMENA
MORISCO, FILOMENA
DIPARTIMENTO DI MEDICINA CLINICA E CHIRURGIA
Long-term outcome of interferon-alfa induced thyroid autoimmunity and prognostic influence of thyroid autoantibodies pattern at the end of treatment.
2001 Carella, C; Mazziotti, G; Morisco, Filomena; Manganella, G; Rotondi, M; Tuccillo, C; Sorvillo, F; Caporaso, Nicola; Amato, G.
Temporal relationship between the appearance of thyroid autoantibodies and development of destructive thyroiditis in patients undergoing treatment with two different type-1interferons for HCV-related chronic hepatitis: A prospective study.
2002 Mazziotti, G; Sorvillo, F; Stornaiuolo, G; Rotondi, M; Morisco, Filomena; Ruberto, M; Cioffi, M; Amato, G; Caporaso, Nicola; Gaeta, Gb; Carella, C.
The addiction of ribavirin to interferon-alpha therapy in patients with hepatitis C virus-related chronic hepatitis does not modify the thyroid autoantibody pattern but increases the risk of developing hypothyroidism.
2002 Carella, C; Mazziotti, G; Morisco, Filomena; Rotondi, M; Cioffi, M; Tuccillo, C; Sorvillo, F; Caporaso, Nicola; Amato, G.
Incidence of site effects during therapy with different types of alpha interferon: a randomized controlled trial compared recombinant alpha 2-b versus leukocyte interferon in the therapy of naives patients with chronic hepatitis C
2002 Ascione, A; DE LUCA, M; DI COSTANZO, Gg; Picciotto, Fp; GALEOTA LANZA, A; Canestrini, C; Morisco, Filomena; Tuccillo, C; Caporaso, Nicola
Interferon-related thyroid autoimmunity and long-term clinical outcome of chronic hepatitis C.
2001 Morisco, Filomena; Mazziotti, G; Rotondi, M; Tuccillo, C; Iasevoli, P; DEL BUONO, A; Sorvillo, F; Amato, G; Marmo, R; Caporaso, Nicola; Carella, C.
Usefulness of a liver biopsy in the evaluation of patients with elevated ALT values and serological markers of hepatitis viral infection
2001 Andriulli, A; Festa, V; Leandro, G; Rizzetto, M; Aigo, Members; Morisco, Filomena
Spread of hepatitis C virus infection within families
1998 Caporaso, Nicola; Ascione, A; Stroffolini, T; INVESTIGATORS OF AN ITALIAN MULTICENTER, Group; Morisco, Filomena
Serum insulin-like growth factor I evaluation as a useful tool for predicting the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis: a prospective study.
2002 Mazziotti, G; Sorvillo, F; Morisco, Filomena; Carbone, A; Rotondi, M; Stornaiuolo, G; Precone, D; Cioffi, M; Gaeta, Gb; Caporaso, Nicola; Carella, C.
epidemiologia dei virus epatitici in Italia
2011 Caporaso, Nicola; R., Granata; M., Guarino; I., Loperto; L., Donnarumma; A., Mariniello; E., Clery; F., Auriemma; C., Ferraiuoli; Morisco, Filomena
Longitudinal study of thyroid autoimmunity and function, before, during and after recombinant interferone alfa-2a (fIFN -2a) therapy.
1993 C., Carella; G., Amato; Caporaso, Nicola; Morisco, Filomena; Biondi, Bernadette; G., Lombardi; A., Bellastella
Proton Transfer Reaction Time of Flight Mass Spectometry (PTR-ToF-MS) for in vivo breath analysis of rats under different diet conditions
2011 E., Aprea; F., Biasioli; L., Cappellin; C., Soukoulis; F., Gasperi; Morisco, Filomena; G., D'Argenio; V., Lembo; V., Fogliano; Caporaso, Nicola
Effects of coffee and its components in a rat model of NASH.
2009 Vitaglione, Paola; Mazzone, G.; Amoruso, D. C.; Monaco, E.; Visone, C.; Romano, A.; Morisco, Filomena; Caporaso, Nicola; D’Argenio, G.; Fogliano, Vincenzo
I PREDITTORI DI SVR GENETICI E VIROLOGICI.
2012 Morisco, Filomena
presentazione die sperienze cliniche
2008 Morisco, Filomena
Il ruolo della dieta e dell' alcol nell'induzione e nella progressione del danno epatico.
2008 Caporaso, Nicola; D., Amoruso; Morisco, Filomena
epatite da HCV:eleggibilità al trattamento
2010 Morisco, Filomena
Il paziente experienced:quali strategie terapeutiche
2011 Morisco, Filomena
Gli antiossidanti della dieta mediterranea e la NAFLD
2010 Morisco, Filomena
Reactivation of hepatitis B or C in patients with IBD receiving immunosuppressive drugs. A multicentre study
2009 Morisco, Filomena; Castiglione, Fabiana; A., Rispo; T., Stroffolini; R., Vitale; S., Sansone; A., Orlando; M., Vecchi; G., Riegler; R., Marmo; Caporaso, Nicola
Functional intestinal disorders: how to improve diagnosis and treatment in general practice
2010 Caporaso, Nicola; Morisco, Filomena; Penagini, R.
| Titolo | Tipologia | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|---|
| Long-term outcome of interferon-alfa induced thyroid autoimmunity and prognostic influence of thyroid autoantibodies pattern at the end of treatment. | 1.1 Articolo in rivista | 2001 | Carella, C; Mazziotti, G; Morisco, Filomena; Manganella, G; Rotondi, M; Tuccillo, C; Sorvillo, F; Caporaso, Nicola; Amato, G. | |
| Temporal relationship between the appearance of thyroid autoantibodies and development of destructive thyroiditis in patients undergoing treatment with two different type-1interferons for HCV-related chronic hepatitis: A prospective study. | 1.1 Articolo in rivista | 2002 | Mazziotti, G; Sorvillo, F; Stornaiuolo, G; Rotondi, M; Morisco, Filomena; Ruberto, M; Cioffi, M; Amato, G; Caporaso, Nicola; Gaeta, Gb; Carella, C. | |
| The addiction of ribavirin to interferon-alpha therapy in patients with hepatitis C virus-related chronic hepatitis does not modify the thyroid autoantibody pattern but increases the risk of developing hypothyroidism. | 1.1 Articolo in rivista | 2002 | Carella, C; Mazziotti, G; Morisco, Filomena; Rotondi, M; Cioffi, M; Tuccillo, C; Sorvillo, F; Caporaso, Nicola; Amato, G. | |
| Incidence of site effects during therapy with different types of alpha interferon: a randomized controlled trial compared recombinant alpha 2-b versus leukocyte interferon in the therapy of naives patients with chronic hepatitis C | 1.1 Articolo in rivista | 2002 | Ascione, A; DE LUCA, M; DI COSTANZO, Gg; Picciotto, Fp; GALEOTA LANZA, A; Canestrini, C; Morisco, Filomena; Tuccillo, C; Caporaso, Nicola | |
| Interferon-related thyroid autoimmunity and long-term clinical outcome of chronic hepatitis C. | 1.1 Articolo in rivista | 2001 | Morisco, Filomena; Mazziotti, G; Rotondi, M; Tuccillo, C; Iasevoli, P; DEL BUONO, A; Sorvillo, F; Amato, G; Marmo, R; Caporaso, Nicola; Carella, C. | |
| Usefulness of a liver biopsy in the evaluation of patients with elevated ALT values and serological markers of hepatitis viral infection | 1.1 Articolo in rivista | 2001 | Andriulli, A; Festa, V; Leandro, G; Rizzetto, M; Aigo, Members; Morisco, Filomena | |
| Spread of hepatitis C virus infection within families | 1.1 Articolo in rivista | 1998 | Caporaso, Nicola; Ascione, A; Stroffolini, T; INVESTIGATORS OF AN ITALIAN MULTICENTER, Group; Morisco, Filomena | |
| Serum insulin-like growth factor I evaluation as a useful tool for predicting the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis: a prospective study. | 1.1 Articolo in rivista | 2002 | Mazziotti, G; Sorvillo, F; Morisco, Filomena; Carbone, A; Rotondi, M; Stornaiuolo, G; Precone, D; Cioffi, M; Gaeta, Gb; Caporaso, Nicola; Carella, C. | |
| epidemiologia dei virus epatitici in Italia | 4.1 Articoli in Atti di convegno | 2011 | Caporaso, Nicola; R., Granata; M., Guarino; I., Loperto; L., Donnarumma; A., Mariniello; E., Clery; F., Auriemma; C., Ferraiuoli; Morisco, Filomena | |
| Longitudinal study of thyroid autoimmunity and function, before, during and after recombinant interferone alfa-2a (fIFN -2a) therapy. | 1.5 Abstract in rivista | 1993 | C., Carella; G., Amato; Caporaso, Nicola; Morisco, Filomena; Biondi, Bernadette; G., Lombardi; A., Bellastella | |
| Proton Transfer Reaction Time of Flight Mass Spectometry (PTR-ToF-MS) for in vivo breath analysis of rats under different diet conditions | 4.1 Articoli in Atti di convegno | 2011 | E., Aprea; F., Biasioli; L., Cappellin; C., Soukoulis; F., Gasperi; Morisco, Filomena; G., D'Argenio; V., Lembo; V., Fogliano; Caporaso, Nicola | |
| Effects of coffee and its components in a rat model of NASH. | 4.1 Articoli in Atti di convegno | 2009 | Vitaglione, Paola; Mazzone, G.; Amoruso, D. C.; Monaco, E.; Visone, C.; Romano, A.; Morisco, Filomena; Caporaso, Nicola; D’Argenio, G.; Fogliano, Vincenzo | |
| I PREDITTORI DI SVR GENETICI E VIROLOGICI. | 8.02 Comunicazioni a Convegni o Seminari | 2012 | Morisco, Filomena | |
| presentazione die sperienze cliniche | 8.02 Comunicazioni a Convegni o Seminari | 2008 | Morisco, Filomena | |
| Il ruolo della dieta e dell' alcol nell'induzione e nella progressione del danno epatico. | 4.1 Articoli in Atti di convegno | 2008 | Caporaso, Nicola; D., Amoruso; Morisco, Filomena | |
| epatite da HCV:eleggibilità al trattamento | 8.02 Comunicazioni a Convegni o Seminari | 2010 | Morisco, Filomena | |
| Il paziente experienced:quali strategie terapeutiche | 8.02 Comunicazioni a Convegni o Seminari | 2011 | Morisco, Filomena | |
| Gli antiossidanti della dieta mediterranea e la NAFLD | 8.02 Comunicazioni a Convegni o Seminari | 2010 | Morisco, Filomena | |
| Reactivation of hepatitis B or C in patients with IBD receiving immunosuppressive drugs. A multicentre study | 8.02 Comunicazioni a Convegni o Seminari | 2009 | Morisco, Filomena; Castiglione, Fabiana; A., Rispo; T., Stroffolini; R., Vitale; S., Sansone; A., Orlando; M., Vecchi; G., Riegler; R., Marmo; Caporaso, Nicola | |
| Functional intestinal disorders: how to improve diagnosis and treatment in general practice | 1.1 Articolo in rivista | 2010 | Caporaso, Nicola; Morisco, Filomena; Penagini, R. |